Senior insider sale
General Counsel at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$22.6K
13.23K shares
What this filing means
PAUL ANDREA plans to sell 13.23K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $22.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2025ACC: 0001725160-25-000020
Officer· General Counsel
Since Aug 2022
13.23K
Shares to sell
$22.6K
Approx. market value
13.23K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/1/2025
13.23KTotal acquired13.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2025 | Restricted Stock Unit Release NA | 13.23K | — |
| Total | 13.23K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.23K
Market value
$22.6K
2/3/2025
Total
Units
13.23K
Value
$22.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/3/2025 | 13.23K | $22.6K | NASDAQ | Planned |
| Total | 13.23K | $22.6K | ||